These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 18313980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
    Vucic S, Cheah BC, Kiernan MC.
    Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
    [Abstract] [Full Text] [Related]

  • 3. Cortical excitability distinguishes ALS from mimic disorders.
    Vucic S, Cheah BC, Yiannikas C, Kiernan MC.
    Clin Neurophysiol; 2011 Sep; 122(9):1860-6. PubMed ID: 21382747
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S, Lin CS, Cheah BC, Murray J, Menon P, Krishnan AV, Kiernan MC.
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cortical excitability of amyotrophic lateral sclerosis: transcranial magnetic stimulation study.
    Khedr EM, Ahmed MA, Hamdy A, Shawky OA.
    Neurophysiol Clin; 2011 May; 41(2):73-9. PubMed ID: 21624709
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis.
    Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N.
    J Neurol; 2002 Dec; 249(12):1723-8. PubMed ID: 12529797
    [Abstract] [Full Text] [Related]

  • 15. Cortical hyperexcitability and the split-hand plus phenomenon: pathophysiological insights in ALS.
    Bae JS, Menon P, Mioshi E, Kiernan MC, Vucic S.
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):250-6. PubMed ID: 24555863
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX, Mao X, Hays AP, Floyd AG, Battista V, Montes J, Hayes S, Dashnaw S, Kaufmann P, Gordon PH, Hirsch J, Levin B, Rowland LP, Shungu DC.
    Neurology; 2007 Apr 24; 68(17):1402-10. PubMed ID: 17452585
    [Abstract] [Full Text] [Related]

  • 19. Impaired interhemispheric inhibition in amyotrophic lateral sclerosis.
    Karandreas N, Papadopoulou M, Kokotis P, Papapostolou A, Tsivgoulis G, Zambelis T.
    Amyotroph Lateral Scler; 2007 Apr 24; 8(2):112-8. PubMed ID: 17453640
    [Abstract] [Full Text] [Related]

  • 20. Transcallosal inhibition in amyotrophic lateral sclerosis.
    Wittstock M, Wolters A, Benecke R.
    Clin Neurophysiol; 2007 Feb 24; 118(2):301-7. PubMed ID: 17140846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.